Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: Comparison with preoperative clinical parameters and primary tumor characteristics

Clinical Cancer Research

Volumn 7, Issue 12, 2001, Pages 4122-4129

  Naume, Bjørn ^a   Kvalheim, Gunnar ^a   Borgen, Elin ^a   Nesland, Jahn M ^a   Qvist, Hanne ^a   Kåresen, Rolf ^b   Sauer, Torill ^b   Kumar, Theresa ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CYTOKERATIN; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGED; ARTICLE; BONE MARROW; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CELL SEPARATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; MORPHOMETRICS; ONCOGENE C ERB; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL;

ANTIBODIES, MONOCLONAL; BIOPSY, NEEDLE; BONE MARROW; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPHATIC METASTASIS; NEOPLASM STAGING; POSTMENOPAUSE; PREMENOPAUSE;

EID: 0035672967     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Breast cancer screening with mammography. Overview of Swedish randomized trials
2. Mammography screening in Norway: Results from the first screening round in four counties and cost effectiveness of a modeled nationwide screening
3. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomised trials involving 31 recurrences and 24000 deaths among 75000 women
4. Potential pathological application of immunocytochemical methods to the detection of micrometastasis
5. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen
6. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow
7. Frequent down-regulation of major histocompatibility class I expression on individual micrometastatic carcinoma cells
8. Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies
9. Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer
10. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
11. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: Towards a novel surrogate test to monitor adjuvant therapies of solid tumours
12. Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years’ follow-up
13. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases
14. Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: Results of a 3-year median follow-up
15. Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal
16. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients
17. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases
18. Prognostic significance of bone marrow micrometastases in patients with gastric cancer
19. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer
20. Standardisation of the immunocytochemical detection of cancer cells in bone marrow and blood. I. Establishment of objective criteria for the evaluation of immunostained cells
21. An immunological enrichment method for epithelial cells from peripheral blood
22. Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients
23. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood
24. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
25. Detection and characterization of carcinoma cells in the blood
26. Immunocytochemical detection of isolated epithelial cells in bone marrow: Non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
27. Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
28. Prognostic value of steroid hormone receptors: Multivariate analysis of systematically untreated patients with node-negative breast cancer
29. Estrogen receptor level and other factors in early recurrence of breast cancer
30. Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene
31. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast
32. p53 gene mutations are not required for early dissemination of cancer cells
33. Classification of isolated tumor cells and micrometastasis
34. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma
35. Re: Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal status
36. Human lymphoid cells express epithelial membrane antigen
37. Expression of MUC1 epitopes on normal bone marrow: Implications for detection of micrometastatic tumor cells
38. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system
39. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging
40. The use of automated microscopy for the detection of disseminated tumor cells (micrometastases) in bone marrow